SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-052726
Filing Date
2020-10-01
Accepted
2020-10-01 18:39:05
Documents
1
Period of Report
2020-10-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4683
  Complete submission text file 0001209191-20-052726.txt   6028
Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Issuer) CIK: 0001633932 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address 75 HARVARD ST. NEWTONVILLE MA 02460
Business Address
Brettman Ari David (Reporting) CIK: 0001826320 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37410 | Film No.: 201217480